Literature DB >> 17372828

A case of hyperthyroidy developing in "pegylated-interferon" therapy.

Mehmet Aslan1, Yasar Nazligul, Nurten Aksoy, Nevin Yilmaz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372828     DOI: 10.1007/s10620-006-9318-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  18 in total

1.  Chronic hepatitis B: update of recommendations.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

Review 2.  Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.

Authors:  Yun-Fan Liaw; Nancy Leung; Richard Guan; George K K Lau; Ismail Merican; Geoff McCaughan; Edward Gane; Jia-Horng Kao; Masao Omata
Journal:  Liver Int       Date:  2005-06       Impact factor: 5.828

Review 3.  Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature.

Authors:  L K Koh; F S Greenspan; P P Yeo
Journal:  Thyroid       Date:  1997-12       Impact factor: 6.568

Review 4.  Side effects of alpha interferon in chronic hepatitis C.

Authors:  G Dusheiko
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

5.  Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.

Authors:  Fumina Doi; Satoru Kakizaki; Hitoshi Takagi; Masami Murakami; Naondo Sohara; Toshiyuki Otsuka; Takehiko Abe; Masatomo Mori
Journal:  Liver Int       Date:  2005-04       Impact factor: 5.828

Review 6.  Biological basis for the clinical use of interferon.

Authors:  F Dianzani
Journal:  Gut       Date:  1993       Impact factor: 23.059

7.  Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis.

Authors:  D K Wong; A M Cheung; K O'Rourke; C D Naylor; A S Detsky; J Heathcote
Journal:  Ann Intern Med       Date:  1993-08-15       Impact factor: 25.391

8.  Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.

Authors:  A Abuchowski; T van Es; N C Palczuk; F F Davis
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

9.  Long-term follow-up in a randomised controlled trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infection.

Authors:  A S Lok; C L Lai; P C Wu; E K Leung
Journal:  Lancet       Date:  1988-08-06       Impact factor: 79.321

10.  Thyroiditis after treatment with interleukin-2 and interferon alpha-2a.

Authors:  G Pichert; L M Jost; L Zöbeli; B Odermatt; G Pedia; R A Stahel
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.